The efficacy and safety of insulin lispro in obese patients with type 2 diabetes mellitus: a retrospective meta-analysis of seven randomized controlled trials
2014
Abstract
Insulin treatment is achieved comparable compensation in obese and nonobese patients DM2T. Insulin lispro is a suitable and safe prandial insulin analogue for the treatment of obese patients with diabetes.
